Trulieve Closes Oversubscribed $115.5 Million Financing

Trulieve Cannabis (CSE: TRUL) has closed its previously announced private placement, raising gross proceeds of C$115,517,500. The offering saw the full over allotment exercised by the underwriters, resulting in a total of 4,715,000 subordinate voting shares of the issuer being sold.

Securities were sold at a price of $24.50 per subordinate voting share under the terms of the placement, with funds to be used primarily for business development and general working capital. The offering was lead by Canaccord Genuity whom acted as lead underwriter alongside a syndicate.

The private placement was announced by Trulieve last week, with the initial value of the raise pegged at C$100.5 million. The financing was announced shortly after the company informed the market that it would be entering the Pennsylvania market with the acquisition of both a cannabis cultivation operation as well as a dispensary operator, for $46 million and US$20 million respectively, before earn-out payments are factored in.

Trulieve Cannabis last traded at $25.40 on the CSE.


Information for this briefing was found via Sedar and Trulieve Cannabis Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

First Majestic Posts Record Quarterly Silver Production In Q3

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

Related News

Trulieve Receives Backlash Online From Alleged Employees Over Handling Of COVID-19

It appears that Trulieve Cannabis (CSE: TRUL) is facing a slight public relations issue currently....

Friday, July 17, 2020, 10:38:30 PM

US Cannabis: Stifel Expects Growth To Decelerate In Q4 Earnings

On February 2nd, Stifel-GMP put out their fourth quarter 2021 earnings preview, calling it “The...

Wednesday, February 9, 2022, 04:33:00 PM

Trulieve: Canaccord Reiterates $97 Price Target After Results

On November 15th, Trulieve Cannabis (CSE: TRUL) reported its third quarter results, announcing record revenues...

Friday, November 19, 2021, 10:31:00 AM

Trulieve Posts $224.1 Million In Q3 Revenues, Positive Net Income

Trulieve Cannabis (CSE: TRUL) this morning reported its third quarter financial results for 2021. The...

Monday, November 15, 2021, 07:30:59 AM

Trulieve Insider Sales In August Climb To $23.1 Million

It appears our article yesterday morning on Trulieve Cannabis (CSE: TRUL) insider selling was slightly.....

Saturday, September 5, 2020, 10:14:49 AM